Chemiluminescence assay improves specificity of hepatitis C antibody detection

Clinical Chemistry

Volumn 49, Issue 6, 2003, Pages 940-944

  Dufour, D Robert ^a,b   Talastas, Mageli ^a   Fernandez, Maria D A ^a   Harris, Barbara ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; ANALYTIC METHOD; ANTIBODY DETECTION; ARTICLE; CHEMOLUMINESCENCE; ENZYME IMMUNOASSAY; FEMALE; HEPATITIS C; HUMAN; IMMUNOBLOTTING; INTERMETHOD COMPARISON; MALE; SENSITIVITY AND SPECIFICITY;

ANTIBODIES, VIRAL; CHEMILUMINESCENT MEASUREMENTS; FALSE POSITIVE REACTIONS; HEPACIVIRUS; HUMANS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; MASS SCREENING; SENSITIVITY AND SPECIFICITY; VETERANS;

HEPATITIS C VIRUS;

EID: 0037683348     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/49.6.940     Document Type: Article

References (26)

1. Alter HJ, Tegtmeier GE, Jett BW, Quan S, Shih JW, Bayer WL, et al. The use of a recombinant immunoblot assay in the interpretation of anti-hepatitis C virus reactivity among prospectively followed patients, implicated donors, and random donors. Transfusion 1991;31:771-6.
2. Chaudhary RK, Frenette S, Mo T. Evaluation of hepatitis C virus kits. J Clin Microbiol 1991;29:2616-7.
3. Courouce AM, Janot C. Recombinant immunoblot assay first and second generations on 732 blood donors reactive for antibodies to hepatitis C virus by ELISA. The Hepatitis Study Group of the French Society of Blood Transfusion. Vox Sang 1991;61:177-80.
4. Wang JT, Wang TH, Lin JT, Sheu JC, Lin SM, Sung JL, et al. Recombinant immunoblot assay for hepatitis C antibody in patients with posttransfusion non-A, non-B hepatitis. J Med Virol 1991;34:172-5.
5. Giulivi A, Aye MT, Gray E, Scalia V, Gill P, Cheng G. Anti-hepatitis C virus (HCV) screening at a Canadian Red Cross center: significance of a positive c100 HCV enzyme-linked immunosorbent assay. Transfusion 1992;32:309-11.
6. Lin HH, Hsu HY, Chang MH, Wang JT, Chen PJ, Chen DS. Correlation between ELISA and recombinant immunoblot assay in serum samples positive for anti-HCV. J Formos Med Assoc 1992;91:729-30.
7. Aceti A, Taliani G, Bruni R, Sharif OS, Moallin KA, Celestino D, et al. Hepatitis C virus infection in chronic liver disease in Somalia. Am J Trop Med Hyg 1993;48:581-4.
8. Bryan JP, Sjogren MH, Malone JL, MacArthy P, Kao TC, Wagner K, et al. Recombinant immunoblot assays for hepatitis C in human immunodeficiency virus type 1-infected US Navy personnel. J Infect Dis 1993;167:715-9.
9. Frost EH. Investigation of sera reactive to hepatitis C virus by second-generation enzyme immunoassay. J Clin Microbiol 1993;31:163-4.
10. Zhang HY, Kuramoto IK, Mamish D, Sazama K, Holland PV, Zeldis JB. Hepatitis C virus in blood samples from volunteer donors. J Clin Microbiol 1993;31:606-9.
11. Andreu J, Abad MA, Sanchez-Quijano A, Torronteras R, Luque F, Garcia de las Heras J, et al. High rate of nonspecific anti-hepatitis C reactivity amongst homosexual men in comparison with that found in other sexually active groups and blood donors. Viral Hepatitis and AIDS Study Group. J Intern Med 1994;236:73-7.
12. Sakugawa H, Nakasone H, Nakayoshi T, Kinjo F, Saito A, Yakabi S, et al. High proportion of false positive reactions among donors with anti-HCV antibodies in a low prevalence area. J Med Virol 1995;46:334-8.
13. Bar-Shany S, Green MS, Shinar E. False positive tests for anti-hepatitis C antibodies and the problem of notifying blood donors. Int J Epidemiol 1996;25:674-8.
14. dos Santos VA, Azevedo RS, Camargo ME, Alves VA. Serodiagnosis of hepatitis C virus. Effect of new evaluation of cutoff values for enzyme-linked immunosorbent assay in Brazilian patients. Am J Clin Pathol 1999;112:418-24.
15. Kim YS, Lee HS, Ahn YO. Factors associated with positive predictability of the anti-HCV ELISA method with confirmatory RT-PCR. J Korean Med Sci 1999;14:629-34.
16. Goncales NS, Costa FF, Vassallo J, Goncales FL. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay. Rev Inst Med Trop Sao Paulo 2000;42:263-7.
17. Recommendations for the prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998; 47(No. RR-19):1-39.
18. Dufour DR, Talastas M, Fernandez MDA, Harris B, Strader DB, Seeff LB. Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection. Clin Chem 2003;49:479-86.
19. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus (anti-HCV). Centers for Disease Control and Prevention. MMWR Recomm Rep 2003;52(RR-3):1-13,15.
20. Calcagno J, Schiff E, Latimer MJ, Uettwiller-Geiger D, Attar B, Gitnick G, et al. Multicenter outcomes-based evaluation of the VITROS® immunodiagnostic products anti-HCV reagent pack and calibrator (VITROS anti-HCV assay) in patients with signs and symptoms of hepatitis and in patients at risk for hepatitis C infection [Abstract]. Hepatology 2001;34:231A.
21. Abdel-Hamid M, El-Daly M, El-Kafrawy S, Mikhail N, Strickland GT, Fix AD. Comparison of second- and third-generation enzyme immunoassays for detecting antibodies to hepatitis C virus. J Clin Microbiol 2002;40:1656-9.
22. Goubau P, Reynders M, Beuselinck K, Nevens F, Peerlinck K, Desmyter J. Confirmatory strategy of hepatitis C serology based on two screening assays in a diagnostic setting. Acta Clin Belg 1997;42:31-5.
23. Vernelen K, Claeys H, Verhaert A, Volckaerts A, Vermylen C. Significance of NS3 and NS5 antigens in screening for HCV antibody. Lancet 1994;343:853.
24. LaPerche S, Courouce A-M, Lemaire J-M, Coste J, Defer C, Cantaloube J-F. GB virus type C/hepatitis G virus infection in French blood donors with anti-NS5 isolated reactivities by recombinant immunoblot assay for hepatitis C virus. Transfusion 1999;39:790-1.
25. Beld M, Penning M, van Putten M, Lukashov V, van den Hoek A, McMorrow M, et al. Quantitative antibody responses to structural (core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood. Hepatology 1999;29:1288-98.
26. Pawlotsky J, Bastie A, Pellet C, et al.. Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay. J Clin Microbiol 1996;34:80-3.